Non-ergot dopamine agonists and heart failure
- PMID: 30587710
- PMCID: PMC6382895
- DOI: 10.14744/AnatolJCardiol.2018.76299
Non-ergot dopamine agonists and heart failure
Comment in
-
Author`s Reply.Anatol J Cardiol. 2019 Jan;21(1):54. Anatol J Cardiol. 2019. PMID: 30587711 Free PMC article. No abstract available.
Comment on
-
Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography.Anatol J Cardiol. 2018 Oct;20(4):213-219. doi: 10.14744/AnatolJCardiol.2018.65983. Anatol J Cardiol. 2018. PMID: 30297579 Free PMC article.
References
-
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. Authors/Task Force Members;Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical